(Allergan plc)

	AGN latest price $235.5965 (0.23%) ($231.7358 - $236.4362) on Tue. Jun. 14, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.73% (three month average)
RSI	74
Latest Price	$235.5965(0.23%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN advances 2.5% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Value stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(44%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -1.365% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-14%)    IPO(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.365% (StdDev 2.73%)
Hourly BBV	0 ()
Intraday Trend	1%

5 Day Moving Average	$236.64(-0.44%)
10 Day Moving Average	$237.31(-0.72%)
20 Day Moving Average	$230.1(2.39%)
To recent high	-16.7%
To recent low	21.1%
Market Cap	$77.676b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed